Eulicin, an antifungal antibiotic agent, was previously isolated from a species of Streptomyces and described by Charney et al}\ Efficacy and toxicity studies were performed2), and the structure of Eulicin (Fig.l) was determined by Herman et al.3\ In the present communication, we investigated its effect on humanimmunodeficiency virus (HIV) infection and replication. The experiment analyzing effects on primarily infection was performed as follows. H9 cells4) were pretreated with serially diluted eulicin at 37°C for 60 minutes and infected with HIV-1 IIIB at 2x 103 TCID50. The cells were incubated for an additional 60 minutes to permit adsorption of viral particles to cells, then diluted with fresh media 1 : 10 and cultured in a 96 well plate. On day 6, the culture was harvested for reverse transcriptase (RT) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assays. The RT assay was performed as described previously5) to estimate the concentration of viral particles from HIV infected cells. The MTT assay6), based on the mitochondrial reduction of MTT, was utilized to measurethe numberof uninfected and infected living cells after exposure to various concentrations of eulicin. In brief, 100jA of cell suspension was transferred to a new 96 well plate and incubated at 37°C for 4 hours with 10/d of5mg/ml MTT. 100/d of 10% SDS was then added to lyse cells and solubilize MTT formazan. The absorbance was measured on a microplate reader with a test wavelength of 550nm and reference wavelength of 630 nm.
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As shown in Fig. 2 Nevertheless, both infection and replication of HIVwere decreased by eulicin.
In order to determine the mechanism of action of eulicin in early stages of HIV infection, we examined H9 cells were inoculated with HIV and eulicin was added either 60minutes prior to infection, at time zero of infection, or 60 minutes after infection.
the influence of time of exposure to eulicin. H9 cells were exposed to HIV-1 IIIB at a high multiplicity to ensure that the virus replication step was synchronized in the whole cell population and then incubated at 37°C. Eulicin was added at varying times (-60, 0, +60min-utes) before adsorption or after exposure to H9cells. Figure 3 shows that any HIV replication was not influenced by the exposure time of eulicin during the virus adsorption step. This suggests that eulicin interferes with events after penetration as the virus goes through its successive replication. This may provide a therapeutic strategy that is useful for HIVinfection. Furthermore, this agent may provide a tool for gaining a better understanding of the HIV replication.
